TSX : EPRX.TO

Eupraxia Pharmaceuticals Inc. — Earnings Estimates

$9.1 CAD

$0.11 (1.22%)

Volume
89.56K
Average Volume
63.22K
Market Capitalization
$327.03M
P/E Ratio
-6.15
Dividend Yield
0.00%
Price Target
Year High
$12.86
Year Low
$6.87
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$19.30

Annual earnings financials

EPRX.TO financial data with annual/quarterly toggle

EPRX.TO GAAP EPS - Annual & Quarterly

EPRX.TO Sales Revenue - Annual & Quarterly

EPRX.TO Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

EPRX.TO Estimated and Actual Revenue by Quarter
EPRX.TO Estimated and Actual EPS by Quarter
EPRX.TO Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 0 - - - - - -
2028-09-30 0 - - - - - -
2028-06-30 0 - - - - - -
2028-03-31 0 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
EPRX.TO Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 0 -58.87M -58.87M -58.87M - - -
2028-09-30 0 -45.11M -45.11M -45.11M - - -
2028-06-30 0 -18.24M -18.24M -18.24M - - -
2028-03-31 0 -18.55M -18.55M -18.55M - - -
2027-12-31 0 -20.35M -20.35M -20.35M - - -
2027-09-30 0 -19.83M -19.83M -19.83M - - -
EPRX.TO Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 0 - - - 5 -1.03808 -1.03808 -1.03808
2028-09-30 0 - - - 5 -0.79541 -0.79541 -0.79541
2028-06-30 0 - - - 6 -0.32164 -0.32164 -0.32164
2028-03-31 0 - - - 3 -0.32715 -0.32715 -0.32715
2027-12-31 0 - - - 2 -0.35878 -0.35878 -0.35878
2027-09-30 0 - - - 2 -0.34964 -0.34964 -0.34964